Latest

Jun 13, 2022, 20:00 ET Innovent and Etana Jointly Announce the Approval of Bevagen® (Bevacizumab Biosimilar) by the Indonesian Food and Drugs Authority (BPOM)

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high...

Jun 13, 2022, 11:09 ET Asep Medical Inc. Announces Allowance of European Patent for First-Generation Sepsis Diagnostic Technology (SepsetER)

VANCOUVER, BC, June 13, 2022 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) is pleased to...

Jun 10, 2022, 12:02 ET LumiraDx obtient le marquage CE pour le test de l'antigène COVID-19 sur Amira, son nouveau système de test à faible coût

LumiraDx Limited (Nasdaq: LMDX), une société de diagnostic de nouvelle génération au point de service, a annoncé aujourd'hui qu'elle avait obtenu le...

Jun 09, 2022, 22:57 ET Everest Medicines Announces Approval of Trodelvy® in China for Second-Line Metastatic Triple-Negative Breast Cancer

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative...

Jun 09, 2022, 12:05 ET LumiraDx obtiene la marca CE para el Amira System

LumiraDx Limited (Nasdaq: LMDX), una empresa de diagnóstico en el punto de atención de próxima generación, ha anunciado hoy que ha conseguido la...

Jun 09, 2022, 08:33 ET LumiraDx Achieves CE Mark for COVID-19 Antigen Test on Amira, its New Low-Cost Testing System

LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced that it has achieved CE Mark for the Amira...

Jun 09, 2022, 08:33 ET LumiraDx erhält CE-Kennzeichnung für COVID-19-Antigentest auf neuem Low-Cost-Testgerät Amira

LumiraDx Limited (Nasdaq: LMDX), ein Unternehmen der nächsten Generation in der Point-of-Care-(POC)-Diagnostik, hat heute die CE-Kennzeichnung seines ...

Jun 09, 2022, 08:00 ET IceCure Medical's ProSense® Cryoablation System Submitted for Regulatory Approval in Brazil

IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® ...

Jun 08, 2022, 20:30 ET LumiraDx reçoit le marquage CE pour deux tests multiplex : LumiraDx SARS-CoV-2 STAR Complete à double cible et LumiraDx SARS-CoV-2 & Grippe A/B RNA STAR Complete

LumiraDx Limited (Nasdaq: LMDX) a annoncé aujourd'hui avoir obtenu le marquage CE pour deux nouveaux tests moléculaires Fast Lab Solutions, à savoir...

Jun 08, 2022, 12:12 ET LumiraDx recibe la marca CE para dos pruebas multiplex

LumiraDx Limited (Nasdaq: LMDX) anunció hoy que obtuvo la marca CE para dos nuevas pruebas moleculares de Fast Lab Solutions, que incluyen...

Jun 08, 2022, 08:10 ET Gannex Announces U.S. FDA Clearance of Clinical Trial on FXR Agonist ASC42 for Treatment of Primary Biliary Cholangitis

Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) today announces that it has obtained the U.S. FDA clearance for its drug...

Jun 08, 2022, 06:03 ET LumiraDx Receives CE Mark for Two Multiplex Tests: LumiraDx Dual-Target SARS-CoV-2 STAR Complete and LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete

LumiraDx Limited (Nasdaq: LMDX) today announced that it has achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target...

Jun 08, 2022, 06:03 ET LumiraDx erhält CE-Kennzeichnung für zwei neue molekulare Multiplex-Tests: LumiraDx Dual-Target SARS-CoV-2 STAR Complete und LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete

LumiraDx Limited (Nasdaq: LMDX) hat heute die CE-Kennzeichnung für zwei seiner neuen molekularen Fast Lab Solutions-Tests, Dual-Target SARS-CoV-2...

Jun 06, 2022, 23:27 ET Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule ATR Inhibitor ATG-018

Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage global biopharmaceutical company dedicated to discovering,...

Jun 06, 2022, 00:23 ET CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer

CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of...

Jun 01, 2022, 07:49 ET Burning Rock Receives CE Mark for its OverC™ Multi-Cancer Detection Blood Test Kit

Burning Rock Biotech Limited (NASDAQ: BNR, the "Company" or "Burning Rock") announced that it has received CE marking for its OverC™ Multi-Cancer...

May 31, 2022, 08:00 ET Volition Achieves CE Mark for Nu.Q® NETs Test

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced that its Nu.Q® NETs test has been CE...

May 25, 2022, 08:30 ET SeekIn Receives CE Mark Approval for SeekInClarity™ Cancer Treatment Response Monitoring Kit

SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (ConformitéEuropéenne) Mark approval for...

May 25, 2022, 04:41 ET Pfizer Launches 'An Accord for a Healthier World' to Improve Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries

Pfizer Inc. (NYSE: PFE) today launched 'An Accord for a Healthier World.' This groundbreaking initiative aims to provide all of Pfizer's patented,...

May 24, 2022, 06:59 ET Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live...

May 20, 2022, 07:45 ET Braxia Scientific Receives Health Canada Special Access Program Approval to Provide Psilocybin-Assisted Therapy for Depression in Ontario

Health Canada approval is for a patient with the indication of Major Depressive Disorder, in the absence of terminal medical illness or end of life...

May 20, 2022, 05:15 ET LumiraDx Receives WHO Emergency Use Listing for SARS-CoV-2 Ag Test

LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, announced today that its rapid COVID-19 antigen assay, LumiraDx ...

May 19, 2022, 10:52 ET CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing

CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) today announced that the World Health Organization ("WHO") has granted Emergency Use ...

May 18, 2022, 10:58 ET PTC anuncia atualização do rótulo do Translarna™ no Brasil para pacientes não ambulatoriais com distrofia muscular de Duchenne com mutação do tipo nonsense

A PTC Therapeutics, Inc. anunciou hoje que a ANVISA (Agência Nacional de Vigilância Sanitária), a agência reguladora de medicamentos no Brasil,...

May 18, 2022, 10:55 ET PTC anuncia la actualización de la marca Translarna™ en Brasil para pacientes no ambulatorios con mutación sin sentido de la distrofia muscular de Duchenne

PTC Therapeutics, Inc. anunció hoy que la Agencia Nacional de Vigilancia Sanitaria de Brasil, ANVISA (Agência Nacional de Vigilância Sanitária),...